Savaris RF, Fuhrich DG, Duarte RV, Franik S and Ross J. Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials. Sexually Transmitted Infections 2019;95:21–27
Ross JDC, Harding J, Duley L, Montgomery AA, Hepburn T, Tan W, Brittain C, Meakin G, Sprange K, Thandi S, Jackson L, Roberts T, Wilson J, White J, Dewsnap C, Cole M, Lawrence T, on behalf of the G-TOG Collaborative Group. A randomised controlled trial to compare the clinical effectiveness, cost effectiveness and safety of gentamicin and ceftriaxone in the treatment of gonorrhoea (The G-TOG Trial). NIHR Health Technology Assessment Journal 2019 Volume: 23, Issue: 20
Ross JDC, Brittain C, Cole M, Dewsnap C, Harding J, Hepburn T, Jackson L, Keogh M, Lawrence T, Montgomery AA, Roberts TE, Sprange K, Tan W, Thandi S, White J, Wilson J and Duley L, on behalf of the G-ToG Trial Team. Gentamicin compared with Ceftriaxone for the treatment of gonorrhoea: a randomised trial (G-ToG Trial). Lancet 2019;393:2511-2520
Gauly J, Ross JDC, Hall I, Soda I, Armoiry X and Atherton H. Pharmacy-based sexual health services: a systematic review of experiences and attitudes of pharmacy users and pharmacy staff. Sex Trans Infect 2019;95:488-495.
Caswell R, Ross JDC and Lorimer K. Measuring experience and outcomes in patients reporting sexual violence who attend a health care setting: a systematic review. Sex Trans Infect 2019;95:419-427
Toorabally N, Mercer CH, Mitchell KR, Blell M, Burns F, Gilson R, McGregor-Read J, Allan S, de Ruiter A, Dhairyawan R, Fox J, Gilleece Y, Jones R, Mackie N, Obeyesekera S, Post F, Reeves I, Rosenvinge M, Ross J, Sarner L, Sullivan A, Tariq A, Ustianowski A, Sabin CA and Tariq S. Association of HIV status with sexual function in women aged 45-60 in England: results from two national surveys. AIDS Care 2019.
S Mensforth S and Ross JDC. Should we still use azithromycin for gonorrhoea treatment? Sexual Health 2019;16:442–448.
Lowe P, Pilcher K, Pattison H, Whittaker V, Robertson C and Ross JDC. Pregnancy Prevention and Contraceptive Preferences of Online Sex Workers in the UK. The European Journal of Contraception and Reproductive Health Care 2019.
Cole M, Tan W, Fifer H, Brittain Ce, Duley L, Hepburn T, Lawrence T, Montgomery A, Sprange K, Thandi S, Churchward C, Tripodo F, Woodford N and Ross JDC. Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea; the relationship between antibiotic minimum inhibitory concentration and clinical outcome. Journal of Antimicrobial Chemotherapy 2019.
Watkins J, Ross JDC, Thandi S, Brittain C, Kai J and Griffiths F. Acceptability of and Treatment Preferences for Recurrent Bacterial Vaginosis - Topical Lactic Acid Gel or Oral Metronidazole Antibiotic: Qualitative Findings from the VITA Trial. PLoS ONE 2019; 14(11): e0224964.
Lorimer L, DeAmicis L, Dalrymple J, Frankis J, Jackson LJ, Lorgelly P, McMillan L and Ross JDC. A rapid review of sexual wellbeing definitions and measures: should we now include sexual wellbeing freedom? Journal of Sex Research 2019.
Armstrong-Buisseret L, Brittain C, David M, Dean G, Griffiths F, Hepburn T, Jackson L, Kai J, Montgomery A, Roberts T, Thandi S and Ross JDC. Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis. Trials 2019.
Ayinde O, Tan W, Hepburn T and Ross JDC. Factors associated with time to presentation for individuals with symptomatic uncomplicated genital gonorrhoea; a cross sectional cohort study of GToG trial participants. Sex Trans Infect 2020;0:1–7.